Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide-Reference-Cited by-同舟云学术

Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide

Published:2003-11-19 Issue:5 Volume:123 Page:830-835
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Oertel Stephan H.,Papp-Váry Matthias,Anagnostopoulos Ioannis,Hummel Manfred W.,Jonas Sven,Riess Hanno B.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04705.x/fullpdf

Reference24 articles.

1. Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines;Akutsu;Gan To Kagaku Ryoho,1996

2. Carboplatin (CBCDA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer;Bishop;Journal of Clinical Oncology,1987

3. Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma;Cortelazzo;British Journal of Haematology,2001

4. Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder;Davis;Transplant Infectious Disease,2001

5. Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213;Drewinko;Cancer Treatment Reports,1976

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‐Transplant Malignancy and Lymphoproliferative Diseases;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

2. Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies;British Journal of Haematology;2023-03-22

3. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder;Cancers;2022-12-01

4. Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder;Clinical Lymphoma Myeloma and Leukemia;2021-10

5. Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective;Pediatric Blood & Cancer;2021-05-21